Author

N. Pemmaraju

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Assay:clinical cohort / trial· 1 Research Focus:differential expression· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

M. Konopleva· 2 shared A. A. Lane· 1 shared A. Louissaint· 1 shared C. Bueso-Ramos· 1 shared C. DiNardo· 1 shared D. M. Weinstock· 1 shared E. A. Morgan· 1 shared E. Jabbour· 1 shared

Activity by Year

2020-2020 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

M. Konopleva

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Sex-biased ZRSR2 mutations in myeloid malignancies impair plasmacytoid dendritic cell activation and apoptosis

K. Togami, S. S. Chung, V. Madan, L. Cabal-Hierro, J. Taylor, S. S. Kim, G. K. Griffin, M. Ghandi, J. Li, Y. Y. Li, F. Angelot-Delettre, S. Biichle, M. Seiler, S. Buonamici, S. B. Lovitch, , A. A. Lane

The paper identifies sex-biased ZRSR2 mutations in BPDCN that impair pDC activation and apoptosis, linking X chromosome mutations to male-predominant leukemia.

bioRxiv · Oct 29, 2020Cancer Biology

Clinicopathologic Correlates and Natural History of Atypical Chronic Myeloid Leukemia

G. Montalban-Bravo, R. Kanagal-Shamanna, K. Sasaki, L. Masarova, K. Naqvi, E. Jabbour, C. DiNardo, K. Takahashi, M. Konopleva, N. Pemmaraju, T. M. Kadia, F. Ravandi, N. G. Daver, G. M. Borthakur, Z. E. Estrov, , G. Garcia-Manero

This study examines clinicopathologic features and treatment outcomes in 65 patients with atypical chronic myeloid leukemia, identifying key mutations and predictors of survival.

bioRxiv · Sep 10, 2020Cancer Biology